Related Experiment Videos
Gallbladder and biliary tract carcinoma: A comprehensive update, Part 2.
William P Daines1, Vandana Rajagopalan, Michael L Grossbard
1Harvard University, Boston, Massachusetts, USA.
Oncology (Williston Park, N.Y.)
|August 27, 2004
Summary
Gallbladder and bile duct cancers, though rare, are improving with new treatments. Palliative care and chemotherapy enhance quality of life, while surgery offers the only cure for these advanced-stage cancers.
Area of Science:
- Gastroenterology and Hepatology
- Surgical Oncology
- Medical Oncology
Background:
- Gallbladder carcinoma and biliary tract cancers are rare in the US, often diagnosed late due to vague symptoms.
- Historically, these cancers had a poor prognosis, but recent advancements are improving outcomes.
Purpose of the Study:
- To review palliative care and systemic therapy for gallbladder and biliary tract carcinomas.
- To discuss the role of liver transplantation in treating cholangiocarcinomas.
- To provide an update on molecular pathology, imaging, and surgical care (from Part 1).
Main Methods:
- Review of current literature on palliative care, chemotherapy, and liver transplantation for gallbladder and biliary tract cancers.
- Synthesis of information on molecular pathology, imaging, and surgical techniques.
Main Results:
- Complete surgical resection remains the only curative option for gallbladder and biliary tract cancers.
- Palliative biliary decompression and chemotherapy significantly improve patients' quality of life.
- Emerging systemic therapies and liver transplantation offer new treatment avenues.
Conclusions:
- Advances in imaging, surgery, and systemic therapies have improved the outlook for patients with gallbladder and biliary tract cancers.
- Palliative strategies are crucial for enhancing quality of life in advanced disease.
- Multidisciplinary care involving internists and oncologists is essential for managing these complex cancers.